Syndactyly Versus Closed Reduction in 5th Metacarpal Neck Fracture
NCT ID: NCT03434587
Last Updated: 2019-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2016-08-31
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conservative Versus Operative Treatment of Displaced Neck Fractures of the Fifth Metacarpal
NCT00704002
Therapy of Fifth Metacarpal Neck Fractures - Comparing Functional Treatment With Reposition and Finger Splinting
NCT06029374
Conservative or Operative Treatment of Fractures in the Neck of the 5th Metacarpal Bone
NCT01139528
Subcapital and Shaft Fractures of the 5. Metacarpal
NCT01242982
Midterm (Min. 3yr) Follow-up of Patients With Single Spiral/Oblique Finger Metacarpal Fracture
NCT05869331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of our study is to carry out a randomized clinical trial of good methodological quality to assess whether immobilization with syndactyly for 3 weeks does not imply loss of functionality or residual symptoms, avoiding rigidity, postinflammation arthritis or loss of grip strength, demonstrating that early mobilization of fractures of the fifth metacarpal provides clinically satisfactory results compared to prolonged immobilization provided that the volar fracture angle does not exceed 70 ° nor does it produce digital movement disruption.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Syndactyly
Syndactyly
Syndactyly
Syndactyly
Reduction and inmobilization
Closed reduction and splint inmobilization
Reduction and inmobilization
Closed reduction and inmobilization with splint
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Syndactyly
Syndactyly
Reduction and inmobilization
Closed reduction and inmobilization with splint
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the Emergency Department with fracture of 5th metacarpal neck, in acute phase (maximum 72 h of evolution) with a possibility of clinical and radiological follow-up of at least 6 months.
* Willing to participate in the study and give their consent in writing.
Exclusion Criteria
* Patients presenting with more than 72 h of evolution
* Patients with comminuted neck fractures.
* Patients with angulation greater than 70 in the lateral-oblique plane
* Patients with clinical-radiological disruption
* Patients with previous fractures in the metacarpal.
* Patients with open fracture grade II-III Gustilo.
* Patients with bifocal fractures or fractures in another metacarpal-phalanx or carpal bones requiring different treatment.
* Polytraumatized patients requiring further care that prevents them from adjusting to the therapeutic regimen specific to the protocol of isolated metacarpal fractures.
* Patients with congenital anomalies on hand affect
* Patients with a psychic disability (dementia-psychiatric illness or mental disorder) that prevents their collaboration in the follow-up
* Patients with medical or surgical pathologies that at the discretion of the investigator do not allow their participation in the study.
* Patients with inability to understand the nature and purpose of the study and / or to accept written participation in the study.
* Unable to attend the pre-established clinical follow-up.
* Do not wish to participate or give their consent in writing.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samuel Pajares, MD
Role: PRINCIPAL_INVESTIGATOR
IIS-FJD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundacion Jimenez Diaz
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FJD-5MTC-16/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.